|
|
| | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- Basic information |
| Product Name: | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- | | Synonyms: | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)-;methyl (S)-2-((7-chloro-2-(2,6-difluoro-4-sulfamoylphenyl)imidazo[1,2-a]pyridin-3-yl)methyl)morpholine-4-carboxylate;Relicpixant | | CAS: | 2445366-94-7 | | MF: | C20H19ClF2N4O5S | | MW: | 500.9 | | EINECS: | | | Product Categories: | | | Mol File: | 2445366-94-7.mol | ![4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- Structure](CAS/20210305/GIF/2445366-94-7.gif) |
| | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- Chemical Properties |
| density | 1.62±0.1 g/cm3(Predicted) | | pka | 9.37±0.60(Predicted) |
| | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- Usage And Synthesis |
| Uses | Relicpixant is a potent purinoreceptor (P2X) antagonist[1]. | | References | [1] International Nonproprietary Names for Pharmaceutical Substances (INN). WHO Drug Information, Vol. 38, No. 2, 2024. |
| | 4-Morpholinecarboxylic acid, 2-[[2-[4-(aminosulfonyl)-2,6-difluorophenyl]-7-chloroimidazo[1,2-a]pyridin-3-yl]methyl]-, methyl ester, (2S)- Preparation Products And Raw materials |
|